CTSA Program Impact
How CTSA grants accelerate clinical research, improve patient outcomes, and serve communities.

709
Clinical Trials
35.4K
Health-Policy Citations
513
Medical Patents
5590
Grants Funded
145.3K
Scientific Publications
Understanding Impact
What is Impact?
Why it Matters
How to Show It
Impact Stories

Case Study
Protecting Federal Research Funding Through ClinicalTrials.gov Support
Clinical research teams must meet complex federal reporting requirements to maintain accurate public records and protect research continuity. Support from the UC Davis CTSC helped strengthen oversight, consultation, and coordination of ClinicalTrials.gov across the institutional research portfolio. In one case, NIH identified a mismatch between information reported in a Research Performance Progress Report (RPPR) and the corresponding ClinicalTrials.gov record. As part of what appeared to be a new NIH review process, funding actions could not proceed until both systems were aligned. Tiffany T. Norris, M.S., ClinicalTrials.gov Management Specialist with the UC Davis CTSC, helped the study team navigate reporting requirements, reconcile information across systems, and complete the review process. NIH cleared the RPPR and issued the Notice of Award without interruption. Across the portfolio, this ClinicalTrials.gov support function monitored 704 non-cancer studies and identified 69 issues.
704
non-cancer studies monitored for ClinicalTrials.gov compliance
69
issues identified through institutional ClinicalTrials.gov portfolio oversight
1
Notice of Award issued without interruption after discrepancies were resolved
Led by University of California at Davis
Posted July 24, 2026
More Recent Stories

This unique partnership between two CTSAs is addressing pressing health care problems with ethical AI use.

Success Story
UNC’s SLiCE tests brain tumor samples on living tissue, enabling multi-drug screening in days and accelerating precision treatment insights.

Success Story
After 10+ years following 2,300+ participants, MASALA found South Asians face earlier heart risk and helped shift guidelines toward earlier screening.



